| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
|
Eur Urol
|
2010
|
4.18
|
|
2
|
Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
|
Eur Urol
|
2011
|
3.47
|
|
3
|
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
|
Eur Urol
|
2007
|
3.20
|
|
4
|
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
|
J Urol
|
2008
|
2.83
|
|
5
|
Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned.
|
J Urol
|
2006
|
2.82
|
|
6
|
Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence?
|
J Urol
|
2006
|
2.65
|
|
7
|
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.
|
Sci Transl Med
|
2012
|
2.64
|
|
8
|
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.
|
Eur Urol
|
2009
|
2.55
|
|
9
|
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.
|
Eur Urol
|
2008
|
2.46
|
|
10
|
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.
|
Cancer Res
|
2010
|
2.39
|
|
11
|
Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.
|
J Clin Oncol
|
2003
|
2.33
|
|
12
|
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
|
Eur Urol
|
2006
|
2.32
|
|
13
|
Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial.
|
Anesthesiology
|
2014
|
2.25
|
|
14
|
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
|
J Urol
|
2011
|
2.14
|
|
15
|
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
|
Lancet Oncol
|
2012
|
2.06
|
|
16
|
Occlusion of seminal vesicles increases sexual activity in a mouse model.
|
Eur Urol
|
2012
|
2.03
|
|
17
|
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.
|
Am J Pathol
|
2002
|
1.71
|
|
18
|
Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results.
|
J Urol
|
2010
|
1.64
|
|
19
|
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
|
Eur Urol
|
2011
|
1.61
|
|
20
|
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder.
|
Am J Surg Pathol
|
2005
|
1.61
|
|
21
|
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
|
Eur Urol
|
2010
|
1.61
|
|
22
|
Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?
|
J Urol
|
2006
|
1.59
|
|
23
|
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
|
Am J Pathol
|
2007
|
1.58
|
|
24
|
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
|
Eur Urol
|
2012
|
1.52
|
|
25
|
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.
|
Histopathology
|
2011
|
1.46
|
|
26
|
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer?
|
J Urol
|
2012
|
1.45
|
|
27
|
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
|
BJU Int
|
2014
|
1.44
|
|
28
|
Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help?
|
BJU Int
|
2013
|
1.40
|
|
29
|
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?
|
J Clin Oncol
|
2004
|
1.40
|
|
30
|
Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution?
|
Eur Urol
|
2007
|
1.39
|
|
31
|
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical.
|
Eur Urol
|
2011
|
1.37
|
|
32
|
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.
|
Cancer Res
|
2005
|
1.33
|
|
33
|
In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
|
Prostate
|
2009
|
1.33
|
|
34
|
Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
|
Eur Urol
|
2011
|
1.24
|
|
35
|
Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.
|
Stem Cells
|
2012
|
1.19
|
|
36
|
Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique.
|
J Urol
|
2002
|
1.16
|
|
37
|
A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival.
|
J Urol
|
2003
|
1.14
|
|
38
|
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
|
J Clin Oncol
|
2005
|
1.14
|
|
39
|
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
|
J Clin Oncol
|
2004
|
1.12
|
|
40
|
Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
|
Am J Pathol
|
2007
|
1.10
|
|
41
|
Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study.
|
Anesthesiology
|
2010
|
1.10
|
|
42
|
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
|
Prostate
|
2009
|
1.05
|
|
43
|
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
|
BJU Int
|
2013
|
1.03
|
|
44
|
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.
|
Brachytherapy
|
2008
|
1.02
|
|
45
|
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy.
|
Int J Cancer
|
2009
|
1.00
|
|
46
|
Cellular interactions in the tropism of prostate cancer to bone.
|
Int J Cancer
|
2004
|
1.00
|
|
47
|
Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution.
|
J Urol
|
2004
|
1.00
|
|
48
|
Characterization and clinical relevance of ALDHbright populations in prostate cancer.
|
Clin Cancer Res
|
2013
|
0.99
|
|
49
|
Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases.
|
Prostate
|
2010
|
0.95
|
|
50
|
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?
|
Am J Pathol
|
2010
|
0.95
|
|
51
|
The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
|
PLoS One
|
2011
|
0.94
|
|
52
|
Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer.
|
Int J Cancer
|
2006
|
0.94
|
|
53
|
Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all?
|
J Urol
|
2013
|
0.93
|
|
54
|
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer.
|
J Clin Pathol
|
2010
|
0.93
|
|
55
|
Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
|
J Urol
|
2005
|
0.91
|
|
56
|
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
|
Cancer Res
|
2013
|
0.91
|
|
57
|
Mechanisms of nanoparticle-mediated photomechanical cell damage.
|
Biomed Opt Express
|
2012
|
0.91
|
|
58
|
High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.
|
Virchows Arch
|
2011
|
0.90
|
|
59
|
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.
|
Int J Cancer
|
2003
|
0.90
|
|
60
|
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
|
PLoS One
|
2012
|
0.89
|
|
61
|
High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients.
|
Histopathology
|
2011
|
0.89
|
|
62
|
Diagnostic microchip to assay 3D colony-growth potential of captured circulating tumor cells.
|
Lab Chip
|
2012
|
0.89
|
|
63
|
Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.
|
J Urol
|
2004
|
0.89
|
|
64
|
Chronic pelvic pain syndrome in men is associated with reduction of relative gray matter volume in the anterior cingulate cortex compared to healthy controls.
|
J Urol
|
2012
|
0.88
|
|
65
|
Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
|
BJU Int
|
2007
|
0.88
|
|
66
|
MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
|
J Clin Pathol
|
2011
|
0.88
|
|
67
|
High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
|
Hum Pathol
|
2011
|
0.87
|
|
68
|
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
|
J Urol
|
2004
|
0.87
|
|
69
|
Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
|
J Urol
|
2007
|
0.87
|
|
70
|
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
|
Prostate
|
2015
|
0.87
|
|
71
|
Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
|
Curr Opin Urol
|
2013
|
0.86
|
|
72
|
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
|
Prostate
|
2012
|
0.85
|
|
73
|
Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer.
|
PLoS One
|
2013
|
0.85
|
|
74
|
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?
|
BJU Int
|
2005
|
0.84
|
|
75
|
Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.
|
BJU Int
|
2012
|
0.83
|
|
76
|
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.
|
Prostate
|
2014
|
0.83
|
|
77
|
Vasectomy reversal with ultrasonography-guided spermatic cord block.
|
BJU Int
|
2012
|
0.83
|
|
78
|
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.
|
Radiother Oncol
|
2009
|
0.83
|
|
79
|
Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience.
|
Eur Urol
|
2011
|
0.83
|
|
80
|
Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
|
Contrast Media Mol Imaging
|
2012
|
0.82
|
|
81
|
Urethral toxicity vs. cancer control--lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.
|
Brachytherapy
|
2010
|
0.82
|
|
82
|
Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.
|
Strahlenther Onkol
|
2009
|
0.81
|
|
83
|
Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer.
|
Radiat Oncol
|
2014
|
0.81
|
|
84
|
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
|
Int J Urol
|
2014
|
0.81
|
|
85
|
Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?
|
World J Urol
|
2012
|
0.80
|
|
86
|
Lunar tractive forces and renal stone incidence.
|
Emerg Med Int
|
2011
|
0.79
|
|
87
|
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
|
Prostate
|
2008
|
0.79
|
|
88
|
Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries.
|
J Immunol Methods
|
2002
|
0.79
|
|
89
|
Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
|
Am J Surg Pathol
|
2014
|
0.79
|
|
90
|
Induction chemotherapy for unresectable urothelial carcinoma of the bladder.
|
BJU Int
|
2010
|
0.78
|
|
91
|
Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens.
|
Pathology
|
2010
|
0.78
|
|
92
|
Prognostic markers for bladder cancer--are we there yet?
|
Eur Urol
|
2006
|
0.77
|
|
93
|
Novel prototype sewing device, EndoSew®, for minimally invasive surgery: an extracorporeal ileal conduit construction pilot study in 10 patients.
|
BJU Int
|
2013
|
0.76
|
|
94
|
High expression of NPY receptors in the human testis.
|
Mol Cell Endocrinol
|
2011
|
0.76
|
|
95
|
Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries.
|
J Immunol Methods
|
2003
|
0.76
|
|
96
|
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
|
BJU Int
|
2012
|
0.76
|
|
97
|
It is time to move on.
|
Eur Urol
|
2011
|
0.76
|
|
98
|
To transfuse or not to transfuse: is it really a question?
|
Eur Urol
|
2013
|
0.75
|
|
99
|
Positive lymph nodes at lymphadenectomy for prostate cancer: where do we set the tiller?
|
Eur Urol
|
2008
|
0.75
|
|
100
|
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.
|
J Clin Invest
|
2016
|
0.75
|
|
101
|
Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
|
Urol Int
|
2016
|
0.75
|
|
102
|
[Diagnosis, treatment and follow up of prostata cancer].
|
Ther Umsch
|
2008
|
0.75
|
|
103
|
Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms.
|
BJU Int
|
2012
|
0.75
|
|
104
|
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
|
J Urol
|
2006
|
0.75
|
|
105
|
Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens.
|
Virchows Arch
|
2014
|
0.75
|
|
106
|
Radical cystectomy and ileal orthotopic bladder substitution after radical retropubic prostatectomy: functional and oncological results.
|
Urol Int
|
2014
|
0.75
|
|
107
|
Focused issue on urological oncology.
|
Transl Androl Urol
|
2015
|
0.75
|
|
108
|
Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
|
Urol Int
|
2014
|
0.75
|